Report Overview

The global metabolic testing market was pegged at US$ 582.0 billion in 2021 and is expected to witness a CAGR of 7.6% during the forecast period.

Market Fundamentals 

Metabolism is a set of chemical reactions that take place in the body to keep it alive. Metabolic rates vary from person to person and are influenced by factors such as gender, height, weight, age, muscle-to-fat ratios, and current levels of physical activity. Metabolic testing instruments are used to determine metabolic parameters. Metabolism is a collection of processes that occur when an enzyme converts a molecule into a product. There are two types of metabolism: catabolism and anabolism. Catabolism is the breakdown of food to obtain energy, whereas anabolism is the use of catabolic energy to synthesise larger molecules from smaller ones, such as amino acids from proteins. The catabolism and anabolism set of reactions are essential for life to exist.

[878945]

Market Dynamics

Over 650 million adults were obese, and 41 million children under the age of five were obese, according to the World Health Organization (WHO). According to the Global Burden of Disease study, obesity caused the deaths of approximately 4.7 million people. As a result, the rising prevalence of lifestyle diseases such as cardiovascular disease, obesity, and diabetes, as well as technological advancements and healthcare spending, are the primary driving forces in the metabolic testing market.

Market Ecosystem

The global metabolic testing market has been analyzed from five perspectives: by product type, technology, application, end user and region. 

Metabolic Testing Market by Product Type

[9459348]

On the basis of product type, the global metabolic testing market has been segmented into cardiopulmonary exercise testing (CPET), body composition analysis, electrocardiogram, and portable system. The CPET systems segment is expected to account for the largest share of the global metabolic testing market because of the product's accuracy and the increasing prevalence of chronic illness This segment's growth is being fuelled by rising healthcare expenditures and rising disposable income.

Metabolic Testing Market by Technology

Based on technology, the global metabolic testing market has been segmented into Vo2 max analysis, resting energy expenditure (REE), body composition analysis, and others. The VO2 max analysis segment is expected to account for the largest share of the market because of its ability to directly measure oxygen consumption, which other tests attempt to estimate. It is the most commonly prescribed metabolic procedure for athletes, caregivers, and otherwise healthy people.

Metabolic Testing Market by Application

On the basis of application, the global metabolic testing market has been segmented into critical care, lifestyle diseases, and others. The lifestyle diseases segment is expected to dominate the market during the forecast period due to the increasing prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular disease around the world.

Metabolic Testing Market by End User

Based on end user, the global metabolic testing market has been segmented into sports performance labs, hospital & clinics and others. The sports performance segment is expected to dominate the market among end users, owing to the growing number of sports performance labs around the world and the improved quality of lab services in developing regions. The number of calories burned by the body at rest is determined by the resting metabolic rate. Body composition analysis is a physical examination that determines the proportions of various components in the body. It is primarily used in hospitals, clinics, sports fitness centres, and gyms to test/examine metabolic conditions, lifestyle ailments, and dysmetabolic disorders. 

Metabolic Testing Market by Region

North America was the dominant region in the global metabolic testing market and is expected to maintain its dominance during the forecast period. This is due to an increase in the prevalence of diseases related to lifestyle and the availability of advanced healthcare in this region. Because of the presence of key players in the United States and Canada, North America is expected to boost market growth in the near future. The Asia Pacific market is expected to grow at the fastest rate during the forecast period, owing to rising living standards, increased demand for quality medical care, government initiatives, increased healthcare spending, and increased healthcare awareness in this region.

Competitive Landscape

Some of the key players operating the market global metabolic testing market include    

• Cosmed srl 
• Geratherm 
• Medical AG
• General Electric Company
• Vyaire Medical, Inc.
• MGC Diagnostics Corporation
• Microlife Medical Home Solutions, Inc.
• Cortex Biophysik GmbH
• OSI Systems, Inc.
• Korr Medical Technologies, Inc.,
• AEI Technologies, Inc.,
• Endurance Company, LLC,
• CareFusion Corporation 

Strategic Developments

• In July 2021, Kimberly Gandler recently met with AEI Technologies to share some expert anecdotal light on the practical use of VO2 Max testing equipment, as well as the various ways she uses the AEI Technologies MAX-II Metabolic Cart. MAX-II Assistances and Anecdotal Usage.
• In June 2021, Mr. Rudolf Bröcker, Chairman of the Supervisory Board of Geratherm Medical AG, has informed us that he will step down from his position on the Supervisory Board at the conclusion of the Annual General Meeting.
• In November 2021, Global Cosmed S.A. joined The Polish Association of Listed Companies (SEG). Now we can improve our competency in performing our duties as a publicly traded company and work even harder for our shareholders.

Frequently Asked Questions About This Report